306 related articles for article (PubMed ID: 25382245)
1. Identification of known and novel germ cell cancer-specific (embryonic) miRs in serum by high-throughput profiling.
Rijlaarsdam MA; van Agthoven T; Gillis AJ; Patel S; Hayashibara K; Lee KY; Looijenga LH
Andrology; 2015 Jan; 3(1):85-91. PubMed ID: 25382245
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA miR-371a-3p in serum of patients with germ cell tumours: evaluations for establishing a serum biomarker.
Spiekermann M; Belge G; Winter N; Ikogho R; Balks T; Bullerdiek J; Dieckmann KP
Andrology; 2015 Jan; 3(1):78-84. PubMed ID: 25187505
[TBL] [Abstract][Full Text] [Related]
3. Serum Levels of MicroRNA-371a-3p (M371 Test) as a New Biomarker of Testicular Germ Cell Tumors: Results of a Prospective Multicentric Study.
Dieckmann KP; Radtke A; Geczi L; Matthies C; Anheuser P; Eckardt U; Sommer J; Zengerling F; Trenti E; Pichler R; Belz H; Zastrow S; Winter A; Melchior S; Hammel J; Kranz J; Bolten M; Krege S; Haben B; Loidl W; Ruf CG; Heinzelbecker J; Heidenreich A; Cremers JF; Oing C; Hermanns T; Fankhauser CD; Gillessen S; Reichegger H; Cathomas R; Pichler M; Hentrich M; Eredics K; Lorch A; Wülfing C; Peine S; Wosniok W; Bokemeyer C; Belge G
J Clin Oncol; 2019 Jun; 37(16):1412-1423. PubMed ID: 30875280
[TBL] [Abstract][Full Text] [Related]
4. Can germ cell neoplasia in situ be diagnosed by measuring serum levels of microRNA371a-3p?
Radtke A; Cremers JF; Kliesch S; Riek S; Junker K; Mohamed SA; Anheuser P; Belge G; Dieckmann KP
J Cancer Res Clin Oncol; 2017 Nov; 143(11):2383-2392. PubMed ID: 28819887
[TBL] [Abstract][Full Text] [Related]
5. Serum Levels of MicroRNA371a-3p: A Highly Sensitive Tool for Diagnosing and Staging Testicular Germ Cell Tumours: A Clinical Case Series.
Anheuser P; Radtke A; Wülfing C; Kranz J; Belge G; Dieckmann KP
Urol Int; 2017; 99(1):98-103. PubMed ID: 28586780
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic markers for germ cell neoplasms: from placental-like alkaline phosphatase to micro-RNAs.
Rajpert-De Meyts E; Nielsen JE; Skakkebaek NE; Almstrup K
Folia Histochem Cytobiol; 2015; 53(3):177-88. PubMed ID: 26306513
[TBL] [Abstract][Full Text] [Related]
7. microRNA-371a-3p as informative biomarker for the follow-up of testicular germ cell cancer patients.
van Agthoven T; Eijkenboom WMH; Looijenga LHJ
Cell Oncol (Dordr); 2017 Aug; 40(4):379-388. PubMed ID: 28612337
[TBL] [Abstract][Full Text] [Related]
8. Differential expression of miRNAs in the seminal plasma and serum of testicular cancer patients.
Pelloni M; Coltrinari G; Paoli D; Pallotti F; Lombardo F; Lenzi A; Gandini L
Endocrine; 2017 Sep; 57(3):518-527. PubMed ID: 27796811
[TBL] [Abstract][Full Text] [Related]
9. Circulating serum miRNA (miR-367-3p, miR-371a-3p, miR-372-3p and miR-373-3p) as biomarkers in patients with testicular germ cell cancer.
Syring I; Bartels J; Holdenrieder S; Kristiansen G; Müller SC; Ellinger J
J Urol; 2015 Jan; 193(1):331-7. PubMed ID: 25046619
[TBL] [Abstract][Full Text] [Related]
10. High-throughput microRNAome analysis in human germ cell tumours.
Gillis AJ; Stoop HJ; Hersmus R; Oosterhuis JW; Sun Y; Chen C; Guenther S; Sherlock J; Veltman I; Baeten J; van der Spek PJ; de Alarcon P; Looijenga LH
J Pathol; 2007 Nov; 213(3):319-28. PubMed ID: 17893849
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA miR-371a-3p - A Novel Serum Biomarker of Testicular Germ Cell Tumors: Evidence for Specificity from Measurements in Testicular Vein Blood and in Neoplastic Hydrocele Fluid.
Dieckmann KP; Spiekermann M; Balks T; Ikogho R; Anheuser P; Wosniok W; Loening T; Bullerdiek J; Belge G
Urol Int; 2016; 97(1):76-83. PubMed ID: 26989896
[TBL] [Abstract][Full Text] [Related]
12. MicroRNAs as Biomarkers for Germ Cell Tumors.
Nappi L; Nichols C
Urol Clin North Am; 2019 Aug; 46(3):449-457. PubMed ID: 31277739
[TBL] [Abstract][Full Text] [Related]
13. Role of stem cell proteins and microRNAs in embryogenesis and germ cell cancer.
Eini R; Dorssers LC; Looijenga LH
Int J Dev Biol; 2013; 57(2-4):319-32. PubMed ID: 23784843
[TBL] [Abstract][Full Text] [Related]
14. The metastatic potential of seminomatous germ cell tumours is associated with a specific microRNA pattern.
Ernst S; Heinzelmann J; Bohle RM; Weber G; Stöckle M; Junker K; Heinzelbecker J
Andrology; 2020 Nov; 8(6):1687-1698. PubMed ID: 32530514
[TBL] [Abstract][Full Text] [Related]
15. Serum Levels of MicroRNA miR-371a-3p: A Sensitive and Specific New Biomarker for Germ Cell Tumours.
Dieckmann KP; Radtke A; Spiekermann M; Balks T; Matthies C; Becker P; Ruf C; Oing C; Oechsle K; Bokemeyer C; Hammel J; Melchior S; Wosniok W; Belge G
Eur Urol; 2017 Feb; 71(2):213-220. PubMed ID: 27495845
[TBL] [Abstract][Full Text] [Related]
16. The present and future of serum diagnostic tests for testicular germ cell tumours.
Murray MJ; Huddart RA; Coleman N
Nat Rev Urol; 2016 Dec; 13(12):715-725. PubMed ID: 27754472
[TBL] [Abstract][Full Text] [Related]
17. Developing a Highly Specific Biomarker for Germ Cell Malignancies: Plasma miR371 Expression Across the Germ Cell Malignancy Spectrum.
Nappi L; Thi M; Lum A; Huntsman D; Eigl BJ; Martin C; O'Neil B; Maughan BL; Chi K; So A; Black PC; Gleave M; Wyatt AW; Lavoie JM; Khalaf D; Bell R; Daneshmand S; Hamilton RJ; Leao RRN; Nichols C; Kollmannsberger C
J Clin Oncol; 2019 Nov; 37(33):3090-3098. PubMed ID: 31553692
[TBL] [Abstract][Full Text] [Related]
18. Is relative quantification dispensable for the measurement of microRNAs as serum biomarkers in germ cell tumors?
Spiekermann M; Dieckmann KP; Balks T; Bullerdiek J; Belge G
Anticancer Res; 2015 Jan; 35(1):117-21. PubMed ID: 25550541
[TBL] [Abstract][Full Text] [Related]
19. MicroRNAs miR-371-3 in serum as diagnostic tools in the management of testicular germ cell tumours.
Dieckmann KP; Spiekermann M; Balks T; Flor I; Löning T; Bullerdiek J; Belge G
Br J Cancer; 2012 Nov; 107(10):1754-60. PubMed ID: 23059743
[TBL] [Abstract][Full Text] [Related]
20. MiR-371a-3p Serum Levels Are Increased in Recurrence of Testicular Germ Cell Tumor Patients.
Terbuch A; Adiprasito JB; Stiegelbauer V; Seles M; Klec C; Pichler GP; Resel M; Posch F; Lembeck AL; Stöger H; Szkandera J; Pummer K; Bauernhofer T; Hutterer GC; Gerger A; Stotz M; Pichler M
Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30321995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
